Remifentanil

Remifentanil is a highly potent, ultra-short-acting synthetic opioid analgesic, primarily utilised in surgical settings for effective pain relief and sedation. Classified under the phenylpiperidine group of opioids, remifentanil stands out due to its rapid onset of action, typically within one to three minutes, and an exceptionally brief duration of effect. What makes remifentanil unique in the field of anaesthesia is its metabolism, which occurs through non-specific plasma and tissue esterases, rather than hepatic or renal pathways. This characteristic permits its safe administration across a broader range of patients and allows for swift recovery after discontinuation, making remifentanil a preferred choice in dynamic surgical procedures.

Image source Google

Methohexital

Methohexital: A Comprehensive Review

Methohexital is an ultra-short-acting barbiturate anaesthetic primarily used to induce general anaesthesia and procedural sedation, particularly for brief diagnostic and therapeutic interventions. Marketed under the brand name Brevital, Methohexital works by swiftly depressing central nervous system (CNS) activity, leading to unconsciousness within approximately 30 seconds when administered intravenously. Owing to its rapid onset and short duration of action, Methohexital is especially valuable in outpatient surgical settings, minor interventions, and emergency procedures. As a Schedule IV controlled substance, strict adherence to handling and administration protocols is mandatory.

Image source Google

Triclofos (Pedicloryl)

Triclofos (Pedicloryl) is a chloral hydrate derivative commonly employed as a sedative-hypnotic, especially within paediatric settings. It functions by depressing central nervous system (CNS) activity, promoting sedation that facilitates diagnostic evaluations in young patients. Administered orally, typically as a palatable syrup, Triclofos (Pedicloryl) provides an effective, non-invasive alternative to general anaesthesia for procedures such as EEGs and neuroimaging. This drug remains an essential component in paediatric procedural sedation due to its favourable safety profile and ease of administration.

Image source Google

Diazepam

Diazepam: An Advanced Pharmacological Analysis

Diazepam, a benzodiazepine, serves as a fundamental pharmacological agent due to its anxiolytic, sedative, muscle relaxant, and anticonvulsant properties. Since its introduction in the 1960s, it has remained indispensable in neurological, psychiatric, and perioperative medicine. The mechanism of action of diazepam involves potentiation of gamma-aminobutyric acid (GABA) at GABA-A receptors, leading to neuronal hyperpolarisation and subsequent central nervous system (CNS) depression. Its extended half-life confers advantages in sustained symptom control but also increases the risk of dependence and withdrawal syndromes, necessitating judicious clinical application.

Image source Google